Directory
>
Peggy Scherle
Peggy Scherle
Chief Scientific Officer | Prelude Therapeutics
Wilmington, Delaware, United States
Peggy Scherle
Summary
Peggy Scherle is a seasoned executive in the biological products industry, currently serving as the Chief Scientific Officer at Prelude Therapeutics Incorporated. With a robust background in commercial physical research, she has a wealth of experience leading scientific initiatives and driving innovation in drug development. Peggy held a significant role as Group Vice President at Incyte, where she honed her leadership skills and contributed to the advancement of therapeutic solutions. Her tenure at Prelude Therapeutics, which began in 2018, marks her commitment to pioneering research in the life sciences sector. Peggy's strategic vision and expertise in scientific leadership make her a key player in her field. She operates at the intersection of science and business, ensuring that cutting-edge research translates into viable therapeutic options. Her professional journey reflects a dedication to improving patient outcomes through innovative solutions. Peggy is known for her collaborative approach and ability to inspire teams towards achieving ambitious goals.
Peggy Scherle
Work Experience
Chief Scientific Officer at
Prelude Therapeutics
April 2018 - Present
Group Vice President at
Incyte
February 2002 - March 2018
Frequently Asked Questions about Peggy Scherle
What is Peggy Scherle email address?
Peggy Scherle's primary email address is ********@preludetx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Peggy Scherle work for?
Peggy Scherle is a Chief Scientific Officer at Prelude Therapeutics, a company specializing in Commercial physical research.
How can I directly contact Peggy Scherle?
To contact Peggy Scherle directly, you can use the email address ********@preludetx.com. Complete contact information is available upon registration with Muraena.
Who is Peggy Scherle?
Peggy Scherle is a seasoned executive in the biological products industry, currently serving as the Chief Scientific Officer at Prelude Therapeutics Incorporated. With a robust background in commercial physical research, she has a wealth of experience leading scientific initiatives and driving innovation in drug development. Peggy held a significant role as Group Vice President at Incyte, where she honed her leadership skills and contributed to the advancement of therapeutic solutions. Her tenure at Prelude Therapeutics, which began in 2018, marks her commitment to pioneering research in the life sciences sector. Peggy's strategic vision and expertise in scientific leadership make her a key player in her field. She operates at the intersection of science and business, ensuring that cutting-edge research translates into viable therapeutic options. Her professional journey reflects a dedication to improving patient outcomes through innovative solutions. Peggy is known for her collaborative approach and ability to inspire teams towards achieving ambitious goals.
Peggy`s contact details
********@preludetx.com
Colleagues
Chief Chemistry Officer
Vice President EHS, Lab Operations, & Facilities
Chief Executive Officer and Founder
Chief People Officer
Executive Director, Technical Operations
Vice President, Head of Finance & Controller
Vice President - Drug Discovery
Vice President of Biology
Senior Vice President, Translation Medicine
SVP, Quantitative Clinical Pharmacology